Catalent is a pharmaceutical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker CTLT on the NYSE exchange.
Catalent stock last closed at $62.64, down 3.11% from the previous day, and has decreased 40.33% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.05 percentage points. Catalent stock is currently +53.94% from its 52-week low of $40.69, and -45.69% from its 52-week high of $115.34.
There are currently 180.09M shares of CTLT outstanding. The market cap of CTLT is $11.28B. In the last 24 hours, 2.23M CTLT shares were traded.
You need an online brokerage account in order to access the NYSE market and buy CTLT shares.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro now.Open eToro Account
Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy CTLT stock today.
Now that you've created your account on one of the most highly reviewed stock apps, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring funds into your investment account.
Once you have identified the best place to buy Catalent stock, it's very important to evaluate their stock prior to investing, so you can understand the risk as well as the opportunity.
WallStreetZen was built to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on CTLT's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CTLT's intrinsic value.
Using relative valuations metrics:
You can access more valuation analysis on CTLT's stock here.
Out of 9 sell side analysts who give ratings on CTLT, the consensus analyst rating on Catalent is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Justin Bowers, a bottom 12% analyst from Deutsche Bank maintains CTLT with a hold rating and raises their CTLT price target from $65.00 to $79.00, on Feb 9, 2023.
Tejas Savant, a bottom 9% analyst from Morgan Stanley maintains CTLT with a strong buy rating and raises their CTLT price target from $81.00 to $85.00, on Feb 9, 2023.
Evan Stover, a top 34% analyst from Baird maintains CTLT with a buy rating and raises their CTLT price target from $75.00 to $82.00, on Feb 8, 2023.
Luke Sergott, a bottom 2% analyst from Barclays maintains CTLT with a strong buy rating and raises their CTLT price target from $58.00 to $82.00, on Feb 8, 2023.
David Toung, a top 22% analyst from Argus Research downgrades CTLT to a hold rating, on Nov 7, 2022.
You can dive deeper into what analysts are projecting on the Catalent stock forecast page.
Last year, CTLT earnings were $409.00M. Over the last 5 year, CTLT's earnings have gone up by 31.38% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 15.74%.
Last year, CTLT revenue was $4.76B. Over the last 5 year, CTLT's revenue has increased by 15.65% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 19.6%.
Dive into CTLT's earnings and revenue performance here.
Over the last year, insiders at CTLT have sold more shares than they have bought.
Ricky Hopson, Pres. Clinical Dev Supply Div of CTLT, was the latest CTLT insider to sell. They sold $31,738.48 worth of CTLT shares on Jan 23, 2023.
Learn more about who owns CTLT stock here.
No, Catalent doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
You have two main order types:
Press the Open button and eToro will place the order.
If you want more help with investing in stocks on eToro, click the how to video below:
Now that you own some CTLT shares, you'll want to stay up-to-date on your shares.
Create a watchlist to get notified of the latest news about your CTLT stock.
To summarize, here are the 6 steps you need to take to buy Catalent stock right now:
If you need a place to buy stocks, eToro is our recommended venue.Get Started with eToro Today
If you would like to keep track of your investment in Catalent, hit the button below to create your watchlist.
How much does it cost to buy one Catalent share?
Is now a good time to buy Catalent stock?
What is the best way to buy Catalent stock?